Saudi medical journal · 2025
Prevalence and determinants of hearing loss in systemic lupus erythematosus: A cross-sectional study in a tertiary care center in Saudi Arabia.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Alrumaih Redha A, Alshaik Amal A, Hasan Manal A, Almulla Layan B, Alsamin Sarah I, Alotaibi Jood K, Alattas Batool A, Maawadh Lojain M
Аннотация
OBJECTIVES: To determine the prevalence of hearing loss in patients with systemic lupus erythematosus (SLE) and identify predictive factors associated with its development.
METHODS: A cross-sectional study was conducted at the Rheumatology Clinic of King Fahad Hospital of the University, Al-Khobar, Saudi Arabia, between November 2023 and March 2024، involving patients diagnosed with SLE. Demographic data, clinical presentation, laboratory results, and medication history were collected. Pure-tone audiometry, speech audiometry, and tympanometry were used to assess hearing.
RESULTS: Fifty-three patients with SLE were included. The prevalence of hearing loss was 15%, with 87.5% of cases being sensorineural hearing loss (SNHL). Logistic regression analysis showed that age over 36 years (p=0.020), diabetes mellitus (p=0.039), positive antinuclear antibody (ANA) (p=0.039), cranial nerve disorder (p=0.009), pyuria (p=0.012), and use of hydroxychloroquine (HCQ) (p=0.007) were significantly associated with an increased risk of hearing loss.
CONCLUSION: Hearing loss, particularly SNHL, was observed in SLE patients. Factors such as older age, diabetes mellitus, cranial nerve disorders, pyuria, positive ANA test results, and HCQ use may predict hearing loss. Regular audiological assessments are essential to mitigate this risk.
METHODS: A cross-sectional study was conducted at the Rheumatology Clinic of King Fahad Hospital of the University, Al-Khobar, Saudi Arabia, between November 2023 and March 2024، involving patients diagnosed with SLE. Demographic data, clinical presentation, laboratory results, and medication history were collected. Pure-tone audiometry, speech audiometry, and tympanometry were used to assess hearing.
RESULTS: Fifty-three patients with SLE were included. The prevalence of hearing loss was 15%, with 87.5% of cases being sensorineural hearing loss (SNHL). Logistic regression analysis showed that age over 36 years (p=0.020), diabetes mellitus (p=0.039), positive antinuclear antibody (ANA) (p=0.039), cranial nerve disorder (p=0.009), pyuria (p=0.012), and use of hydroxychloroquine (HCQ) (p=0.007) were significantly associated with an increased risk of hearing loss.
CONCLUSION: Hearing loss, particularly SNHL, was observed in SLE patients. Factors such as older age, diabetes mellitus, cranial nerve disorders, pyuria, positive ANA test results, and HCQ use may predict hearing loss. Regular audiological assessments are essential to mitigate this risk.